Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Novartis
Federal Trade Commission
QuintilesIMS
Boehringer Ingelheim
Moodys
Mallinckrodt
US Department of Justice
Farmers Insurance
Baxter

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040116

« Back to Dashboard

NDA 040116 describes CARISOPRODOL AND ASPIRIN, which is a drug marketed by Heritage Pharms Inc, Novast Labs Ltd, Oxford Pharms, and Sandoz, and is included in four NDAs. It is available from five suppliers. Additional details are available on the CARISOPRODOL AND ASPIRIN profile page.

The generic ingredient in CARISOPRODOL AND ASPIRIN is aspirin; carisoprodol. There are twenty-one drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; carisoprodol profile page.
Summary for 040116
Tradename:CARISOPRODOL AND ASPIRIN
Applicant:Sandoz
Ingredient:aspirin; carisoprodol
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 040116
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 040116 ANDA Eon Labs, Inc. 0185-0724 0185-0724-01 100 TABLET in 1 BOTTLE (0185-0724-01)
CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 040116 ANDA Eon Labs, Inc. 0185-0724 0185-0724-05 500 TABLET in 1 BOTTLE (0185-0724-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;200MG
Approval Date:Apr 25, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Teva
Merck
Deloitte
Federal Trade Commission
McKinsey
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot